1. Home
  2. AMSS vs MBIO Comparison

AMSS vs MBIO Comparison

Compare AMSS & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

N/A

Current Price

$0.24

Market Cap

4.2M

ML Signal

N/A

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.39

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMSS
MBIO
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.1M
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
AMSS
MBIO
Price
$0.24
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 62.0K
36.8K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$3.71
N/A
Revenue Next Year
$20.00
$405.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.35
52 Week High
$2.44
$1.44

Technical Indicators

Market Signals
Indicator
AMSS
MBIO
Relative Strength Index (RSI) 29.50 45.60
Support Level N/A $0.35
Resistance Level $0.39 $0.43
Average True Range (ATR) 0.04 0.03
MACD 0.01 0.01
Stochastic Oscillator 18.97 64.93

Price Performance

Historical Comparison
AMSS
MBIO

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: